Reaktionsgleichung
[CH:1]1[CH:2]=[N:3][C:4]([NH:7][S:8]([C:11]2[CH:12]=[CH:13][C:14]([NH2:17])=[CH:15][CH:16]=2)(=[O:10])=[O:9])=[N:5][CH:6]=1.[CH3:18][O:19][C:20]1[CH:21]=[C:22]([CH2:30][C:31]2[CH:32]=[N:33][C:34]([NH2:38])=[N:35][C:36]=2[NH2:37])[CH:23]=[C:24]([O:28][CH3:29])[C:25]=1[O:26][CH3:27]>>[CH:1]1[CH:2]=[N:3][C:4]([NH:7][S:8]([C:11]2[CH:16]=[CH:15][C:14]([NH2:17])=[CH:13][CH:12]=2)(=[O:10])=[O:9])=[N:5][CH:6]=1.[CH3:18][O:19][C:20]1[CH:21]=[C:22]([CH2:30][C:31]2[CH:32]=[N:33][C:34]([NH2:38])=[N:35][C:36]=2[NH2:37])[CH:23]=[C:24]([O:28][CH3:29])[C:25]=1[O:26][CH3:27]Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
Using 8 ml volumetric pipettes, 8 ml of the sulfadiazine stock solution were mixed with 8 ml of the trimethoprim stock solution to give a sulfadiazine/trimethoprim stock solution of about 4.0/0.8 mg/ml.
Quellen und Nachweise
- ORD-Eintrag
- ord-af3c52da83634aa58e802b36f3b09e79
- Quelldatensatz
- uspto-grants-1998_01
- Patentnummer
- US05707996
Verknüpfte Notizen
Wird geladen…